School of Medicine

Denise M.S. Willers, MD, a clinician renowned for patient-centered care and academic excellence, has been named the new director of the WashU Medicine Division of Academic Specialists in Obstetrics & Gynecology.

WashU Medicine researchers have developed a method to predict when someone is likely to develop symptoms of Alzheimer’s disease using a single blood test.

WashU Medicine researchers have received a grant from the National Institutes of Health (NIH) to continue a study of families with a history of extreme longevity, seeking genetic clues to healthy aging.

Michael J. Greenberg, at WashU Medicine, has received two grants from the National Institutes of Health (NIH) to investigate the complex roles of troponin — a critical protein in the heart — in various forms of heart failure.

Philip Payne, vice chancellor for biomedical informatics and data science at WashU Medicine and chief health AI officer for BJC Health and WashU Medicine, will lead the American Medical Informatics Association.

Research from WashU psychologists finds perception of neighborhood safety affects brain development.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.

Padma Gulur, MD, a physician-scientist and nationally recognized leader in pain management, has been named the head of the Department of Anesthesiology and the inaugural Alex S. Evers MD Distinguished Professor in Anesthesiology at WashU Medicine. Her appointment begins Aug. 1.

A study by researchers at WashU Medicine reveals how the body reprograms stable fat cells to eliminate stubborn fat reserves.

Researchers at WashU Medicine and Weizmann Institute of Science designed a CAR-T cell therapy that reduced amyloid beta plaques in the brains of mice, pointing to a promising new approach for Alzheimer’s disease.